R C Gosselin
Overview
Explore the profile of R C Gosselin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adcock D, Moore G, Kershaw G, Montalvao S, Gosselin R
Int J Lab Hematol
. 2024 Jul;
46(5):777-788.
PMID: 39009028
This guidance document has been prepared on behalf of the International Council for Standardization in Haematology (ICSH). The aim of the document is to provide guidance and recommendations for the...
2.
Adcock D, Gosselin R
Int J Lab Hematol
. 2017 Apr;
39 Suppl 1:37-40.
PMID: 28447415
Prolongation of the activated partial thromboplastin time (APTT) and prothrombin time/international normalized ratio (PT/INR) correlates poorly with plasma concentrations of direct oral anticoagulant agents (DOACS) including direct thrombin and direct...
3.
Letertre L, Gudmundsdottir B, Francis C, Gosselin R, Skeppholm M, Malmstrom R, et al.
J Thromb Haemost
. 2016 Mar;
14(5):1043-53.
PMID: 26924677
Unlabelled: Essentials Simple and fast assaying of different anticoagulants (ACs) is useful in emergent situations. We used highly diluted prothrombin time (dPT) or highly diluted Fiix-PT (dFiix-PT) to assay ACs....
4.
Gosselin R, Estacio E, Song J, Dwyre D
Int J Lab Hematol
. 2016 Feb;
38(2):183-92.
PMID: 26847002
Objective: To verify the manufacturer performance claims of the TEG5000 with traditional laboratory methods. Materials And Methods: Samples were concurrently measured using the TEG5000 analyzer and either PT, APTT, fibrinogen,...
5.
Gosselin R, Adcock D
J Thromb Haemost
. 2016 Jan;
14(5):886-93.
PMID: 26791879
The introduction of direct oral anticoagulant (DOAC) therapy into clinical use in the past 5 years has had significant impact on the clinical laboratory. Clinicians' desire to determine plasma drug...
6.
7.
Gosselin R, Adcock D
Int J Lab Hematol
. 2015 May;
37 Suppl 1:46-51.
PMID: 25976960
Nonvitamin K antagonist oral anticoagulants (NOACs) are being used with increasing frequency due to their safety profile, ease of use, and given that therapeutic monitoring is not required. As these...
8.
Gosselin R, Honeychurch K, Kang H, Dwyre D
Int J Lab Hematol
. 2015 Mar;
37(4):551-9.
PMID: 25766006
Introduction: Current recommendations for coagulation testing storage and thawing are based on historical studies that were performed using unbuffered 3.8% sodium citrate. We sought to measure the effects of freezing...
9.
Gosselin R, Adcock D, Hawes E, Francart S, Grant R, Moll S
Thromb Haemost
. 2014 Nov;
113(1):77-84.
PMID: 25413383
Suitable laboratory methodologies for quantifying the non-vitamin K oral anticoagulants (NOAC) include liquid chromatography-tandem mass spectrometry (LC-MS/MS) or drug-calibrated assays such as the dilute thrombin time for dabigatran or anti-Xa...
10.
Kol A, Nelson R, Gosselin R, Borjesson D
Vet J
. 2013 Jul;
197(3):675-81.
PMID: 23838206
Canine hyperadrenocorticism (HAC) is a common endocrinopathy often associated with hypercoagulability, thrombosis and thromboembolism and it can contribute to increased morbidity and mortality. The condition results in increased, unregulated secretion...